Scarica l'app Stockscreener
0.0425
72.37%
-0.1114
Dopo l'orario di chiusura:
.04
-0.00253
-5.94%
Precedente Chiudi:
$0.1539
Aprire:
$0.038
Volume 24 ore:
811.22K
Relative Volume:
0.11
Capitalizzazione di mercato:
$1.78M
Reddito:
$20.27M
Utile/perdita netta:
$-63.80M
Rapporto P/E:
-0.028
EPS:
-1.52
Flusso di cassa netto:
$-68.35M
1 W Prestazione:
-84.47%
1M Prestazione:
-87.36%
6M Prestazione:
-78.83%
1 anno Prestazione:
-95.62%
Intervallo 1D:
$0.036
$0.05
Intervallo di 1 settimana:
$0.036
$0.17
Portata 52W:
$0.036
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Nome
Carisma Therapeutics Inc
Settore
Industria
Telefono
(267) 491-6422
Indirizzo
3675 MARKET STREET, PHILADELPHIA
Confronta CARM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.0425 | 6.43M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-04-11 | Iniziato | BTIG Research | Buy |
| 2023-10-03 | Iniziato | CapitalOne | Overweight |
| 2023-07-06 | Iniziato | Evercore ISI | Outperform |
| 2023-05-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Carisma Therapeutics Inc Borsa (CARM) Ultime notizie
Understanding Carisma Therapeutics Inc.’s price movementAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Carisma TherapeuticsCEO Steven Kelly to leave effective November 15SEC filing - MarketScreener
Carisma Therapeutics Announces Executive Terminations and Wind-Down - TipRanks
Is Carisma Therapeutics Inc. stock positioned for digital transformationJuly 2025 Momentum & Community Consensus Picks - newser.com
Heatmap analysis for Carisma Therapeutics Inc. and competitorsJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Published on: 2025-10-15 11:31:31 - newser.com
Does Carisma Therapeutics Inc. (W2J) stock trade below intrinsic valueStop Loss & Verified Momentum Stock Watchlist - newser.com
Analyzing recovery setups for Carisma Therapeutics Inc. investorsDollar Strength & High Conviction Investment Ideas - newser.com
Using Bollinger Bands to evaluate Carisma Therapeutics Inc.Trade Risk Assessment & Daily Technical Forecast Reports - newser.com
Is Carisma Therapeutics Inc. a candidate for recovery playQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Key metrics from Carisma Therapeutics Inc.’s quarterly data2025 Institutional Moves & Weekly Market Pulse Updates - newser.com
Carisma Therapeutics, Inc.(NasdaqCM: CARM) dropped from S&P TMI Index - MarketScreener
Volatility clustering patterns for Carisma Therapeutics Inc.2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Visual trend scoring systems applied to Carisma Therapeutics Inc.July 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-13 10:57:01 - newser.com
Will Carisma Therapeutics Inc. stock go up soonWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
How hedge fund analytics apply to Carisma Therapeutics Inc. stockJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
What analyst consensus says on Carisma Therapeutics Inc. stockGap Down & Weekly Top Performers Watchlists - newser.com
What MACD trends signal for Carisma Therapeutics Inc. (W2J) stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Dow Surges 150 Points; US Consumer Sentiment Edges Lower - Benzinga
Carisma Therapeutics stock plunges after Nasdaq delisting notice By Investing.com - Investing.com Nigeria
Carisma Therapeutics stock plunges after Nasdaq delisting notice - Investing.com
Can Carisma Therapeutics Inc. (W2J) stock sustain free cash flowJuly 2025 Levels & Weekly High Conviction Ideas - newser.com
Carisma Therapeutics Faces Nasdaq Delisting and Trading Suspension - TipRanks
Top Executive Sells Thousands of Carisma Therapeutics Shares! - TipRanks
Carisma Therapeutics CSO Sells Shares - TradingView
Is Carisma Therapeutics Inc a good long term investmentTechnology Stock Trends & Free Trend Following Techniques - earlytimes.in
Is Carisma Therapeutics Inc W2J a good long term investmentVolume Weighted Average Price & Low Entry Investment Portfolio - earlytimes.in
Chart overlay techniques for tracking Carisma Therapeutics Inc.Earnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Can machine learning forecast Carisma Therapeutics Inc. recoveryJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Carisma Therapeutics Inc.Weekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
Is Carisma Therapeutics Inc. stock attractive for passive investorsPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
How analysts revise price targets for Carisma Therapeutics Inc. (W2J) stockInsider Selling & AI Enhanced Trading Alerts - newser.com
Why Carisma Therapeutics Inc. (W2J) stock is listed among top recommendationsEarnings Risk Report & Fast Gain Stock Tips - newser.com
Should you wait for a breakout in Carisma Therapeutics Inc.2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
P 500 performance this yearJuly 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Carisma Therapeutics Inc Azioni (CARM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Klichinsky Michael | Chief Scientific Officer |
Oct 07 '25 |
Sale |
0.25 |
56,982 |
14,485 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):